- Fee assured
- Verified this account
- Lower GI
Major research interest is in the treatment of rectal and anal cancer, and chemoradiation. Current areas of research include investigation of resistance mechanisms/predictive factors for response to chemoradiation in anal and rectal cancer, DCE-MRI changes, examination of tumour interstitial pressure and the development of novel chemoradiation regimens. I am also interested in defining an optimal field size for radiation for different stages.
I am intrigued by the evidence that the biologicals have not yet delivered on their original promise in combination with radiation.
I am Principle Investigator of studies in rectal and anal cancer integrating novel drugs into Chemoradiation regimens.
Reference number 2443823
Information for healthcare professionals (Bupa patients only, last 12 months)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 14 days - (5-50)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (1-5)
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)
Clinical supervision and planning for delivery of chemotherapy cycle 1 - 28 days - (1-5)
Clinical supervision of the planning of a course of simple radiotherapy - (1-5)
- Show All (6)...